CAPSTONE THERAPEUTICS CORP COM STK (DE)
CAPS
CAPS was delisted on the 20th of July, 2011.
1 hedge funds and large institutions have $1K invested in CAPSTONE THERAPEUTICS CORP COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
75% less capital invested
Capital invested by funds: $4K → $1K (-$3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MWP
1
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| $1K | – | – | – |
|
|
2
EARNEST Partners
Atlanta,
Georgia
| – | -$3K | -11,100 | Closed |
|
CAPS Hedge Fund Activity: Q3 2014 in Review
1 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) for Q3 2014, worth a combined $1K — down 75% from $4K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CAPS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was EARNEST Partners, exiting entirely with an estimated $3K sold.
- 1 institutional investor held CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) as of Q3 2014, down from 2 in Q2 2014.
- Funds reported $1K of CAPSTONE THERAPEUTICS CORP COM STK (DE) stock for Q3 2014, down 75% quarter-over-quarter.
- 0 funds opened new CAPSTONE THERAPEUTICS CORP COM STK (DE) positions in Q3 2014 and 1 closed out, a net change of -1 holder.
- The largest CAPSTONE THERAPEUTICS CORP COM STK (DE) seller in Q3 2014 was EARNEST Partners, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2014.